Spironolactone and Chlorthalidone-old Drugs, New Uses-but Approach with Caution
Overview
Overview
Journal
Nephrol Dial Transplant
Publisher
Oxford University Press
Specialties
General Surgery
Nephrology
Nephrology
Date
2021 Dec 5
PMID
34865132
Citations
2
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Hypertension in chronic kidney disease-treatment standard 2023.
Georgianos P, Agarwal R Nephrol Dial Transplant. 2023; 38(12):2694-2703.
PMID: 37355779 PMC: 10689140. DOI: 10.1093/ndt/gfad118.
Thiazide diuretics are back in CKD: the case of chlorthalidone.
Minutolo R, De Nicola L, Mallamaci F, Zoccali C Clin Kidney J. 2023; 16(1):41-51.
PMID: 36726437 PMC: 9871852. DOI: 10.1093/ckj/sfac198.
References
1.
Agarwal R, Sinha A, Pappas M, Ammous F
. Chlorthalidone for poorly controlled hypertension in chronic kidney disease: an interventional pilot study. Am J Nephrol. 2014; 39(2):171-82.
DOI: 10.1159/000358603.
View
2.
Albert N, Yancy C, Liang L, Zhao X, Hernandez A, Peterson E
. Use of aldosterone antagonists in heart failure. JAMA. 2009; 302(15):1658-65.
DOI: 10.1001/jama.2009.1493.
View
3.
Juurlink D, Mamdani M, Lee D, Kopp A, Austin P, Laupacis A
. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med. 2004; 351(6):543-51.
DOI: 10.1056/NEJMoa040135.
View
4.
Pitt B, Zannad F, Remme W, Cody R, CASTAIGNE A, Perez A
. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999; 341(10):709-17.
DOI: 10.1056/NEJM199909023411001.
View
5.
Carlsen J, Kober L, Torp-Pedersen C, Johansen P
. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. BMJ. 1990; 300(6730):975-8.
PMC: 1662719.
DOI: 10.1136/bmj.300.6730.975.
View